AN2 Therapeutics, Inc. · NASDAQ:ANTX
Eizen Joshua M sold 5,945 AN2 Therapeutics, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Eizen Joshua M (See Remarks) sold 5,945 AN2 Therapeutics, Inc. shares at US$4.17 for US$24,791, leaving 206,554 shares. Filed Jul 10, 2026 (Form 4).
- Sold
- 5,945 shares
- Price
- US$4.17
- Value
- US$24,791
- Holding after
- 206,554 shares
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Sale | 5,945 | US$4.17 | 206,554 | Direct |
Source
Related
- AN2 Therapeutics, Inc.
- Eizen Joshua M
- AN2 Therapeutics, Inc. shareholders
- Form 4 · Eizen Joshua M · Nov 6, 2026
- Schedule 13G/A · Commodore Capital LP · Nov 16, 2026
- Schedule 13G/A · Eric Easom · Nov 13, 2026
- Schedule 13G/A · Coastlands Capital LP · Nov 13, 2026
- Form 4 · Aziz Kabeer · Oct 13, 2026
- Form 4 · Martin Patricia A. · Oct 13, 2026